Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.17
Delayed Data
As of 4:00pm ET
 +0.07 / +6.36%
Today’s Change
0.58
Today|||52-Week Range
1.85
+21.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash8.0M15.1M10.7M5.1M
 
 
 
 
 
Short Term Investment Cash7.0M7.1M-4.5M-5.5M
 
 
 
 
 
Cash & Short Term Investments8.0M15.1M10.7M5.1M
 
 
 
 
 
 
ReceivablesReceivables669.3K0.0023.7K0.00
 
 
 
 
InventoriesInventories0.000.00--0.00--
 
Current AssetsOther Current Assets189.5K279.8K328.2K438.2K
 
 
 
 
 
Current Assets8.9M15.4M11.0M5.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross336.1K255.1K486.9K512.3K
 
 
 
 
 
Depreciation-283.6K-177.0K-225.2K-293.5K
 
 
 
 
 
Other Assets17.4K18.0K26.0K38.2K
 
 
 
 
 
Total Assets9.0M15.5M11.3M5.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable504.9K158.3K491.6K884.1K
 
 
 
 
 
Accrued Expenses151.2K400.0K417.8K165.4K
 
 
 
 
 
Other Current Liabilities237.9K406.9K427.4K169.5K
 
 
 
 
 
Other Liabilities742.8K565.2K919.0K1.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.001.4M1.5M
 
 
 
Other Liabilities0.000.009.4M9.4M
 
 
 
Total Liabilities742.8K565.2K11.7M11.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity8.2M14.9M-422.2K-6.1M
 
 
 
 
 
Total Shareholder Equity8.2M14.9M-422.2K-6.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding22.5M27.0M32.4M32.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.